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Background: Folate has been shown to play a complex but unclear role in carcinogenesis, with some studies
showing that low folate intake protects against early carcinogenesis while high folate intake promotes advanced
carcinogenesis. Other studies have shown that high folate is associated with decreased breast cancer risk and
overall survival, yet others found no such association.
This study therefore sought to determine the association between red blood folate levels and breast cancer among
women seen at a tertiary Ugandan hospital.
Methods: A case control study was conducted where female patients with a histological diagnosis of breast cancer
were recruited as cases, and females without cancer attending other surgical clinics as controls. Demographics and
social behavior data were collected and 5mls of blood drawn for laboratory testing of red blood cell (RBC) folate,
serum vitamin B12 and RBC count. Ethical approval was obtained.
Results: In this study, a total of 145 women were recruited as 72 cases and 73 controls. The odds of having breast
cancer among women with normal folate levels compared to those with low folate levels were 1.4 (95% CI 0.7
to 2.9) P = 0.290. Ninety participants (63%) had low RBC folate and 53 participants (37%) had normal RBC folate.
Thirty five (45%) of the women from a rural setting had normal folate levels compared to 18(28%) women from an
urban setting.
Conclusions: There was no significant association found between RBC folate and breast cancer among this group
of women in Uganda.
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Folate, a B vitamin (B9) found naturally in many food
sources, particularly in dark green leafy vegetables [1], is
essential for regenerating methionine, the methyl donor
for DNA methylation, and for producing the purines
and pyrimidine thymidylate required for DNA synthesis
and repair [2]. The role of folate is well documented in
the prevention of neural tube defects and is increasingly
studied in relation to cardiovascular disease risk [3-5].
Evidence for its potential role in carcinogenesis is en-
couraging, although the effect is less well studied [3].* Correspondence: mosesg@img.co.ug
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reproduction in any medium, provided the orNumerous studies have examined the association be-
tween folate and both colorectal and lung cancers, but
few have been conducted for breast cancer, even in the
western world [3], and there is as of yet, no consensus
on the association.
In this study, we investigated the association between
low red blood cell (RBC) folate levels and breast cancer.
Most studies have looked at high dietary folate food as a
protective factor against breast cancer and most of these
studies were carried out in countries where either folate
fortification is performed or the incomes and nutritional
status of participants are higher than in Uganda.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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Study setting and design
This was a hospital-based case control study. The study
was carried out at the Breast Clinic at Mulago National
Referral and Teaching Hospital of Makerere, University
College of Health Sciences, Uganda.
Mulago Hospital is located in Kampala, the capital city
of Uganda. Patients seen in Mulago Hospital are referred
from all over the country; however a significant number
of patients are self-referred.
The cases
The study included patients attending the Breast Clinic
with histologically confirmed breast cancer and not re-
ceiving chemotherapy.
Patients who were 18 years of age and above were in-
cluded because breast cancer is rare below this age. Sec-
ondly, 18 years is the minimum age in Uganda at which
written and informed consent is obtained.
Patients who were pregnant, taking folic acid or multi-
vitamin supplementations containing folic acid, taking
anticonvulsants, and patients with a history of menor-
rhagia (menstruation lasting more than seven days) were
excluded.
The control patients
The control patients were without breast cancer or any
other cancer (verified history and clinical examination).
They were recruited from surgical outpatient clinics other
than the Breast Clinic. Excluded from the control group
were pregnant women, participants taking folic acid sup-
plementation or multivitamins containing folic acid, pa-
tients taking anticonvulsants, or those with a history of
menorrhagia (menstruation lasting more than 7 days. Also
excluded were those with benign breast conditions.
Study variables
The following were considered: RBC folate level, age, pa-
rity, age at menarche and menopause, Body Mass Index
(BMI), residence (rural versus urban), use of hormonal
contraception, tobacco use versus no tobacco usage, alco-
hol consumption, hemoglobin level, and serum vitamin
B12 level.
Study procedure
The purpose of the study, the assessment, and sample
collection procedures were carefully explained to each
patient individually. Participants were allowed to ask ques-
tions freely to ensure that they understood the intention
of the study.
Screening for suitability included history taking and
physical examination.
Written informed consent was obtained from those who
satisfied the inclusion criteria and they were subsequentlyenrolled in the study on a consecutive basis. Those who
did not meet the inclusion criteria as well as those who
declined to participate in this study were offered the care
that had been scheduled.
Under aseptic conditions, 5mls of blood from each
participant was drawn from the antecubital vein. Follow-
ing this, 3mls were put into a red top vacutainer and
2mls were put into a purple top vacutainer containing
ethylenediaminetetraacetic acid (EDTA). The samples
were transported to the lab for processing at below room
temperature and within two hours. Blood samples were
stored in a freezer at −20°C to ensure that they were
available in case the need for re-examination arose in
the near future.
Samples were processed by using the COBAS e601
analyzer (Roche diagnostics, Indianapolis, USA) and two
lab technologists processed the samples.Data collection and analysis
Interviews were conducted using a pretested question-
naire and laboratory results were recorded. The labora-
tory result forms were safely and confidentially stored.
Data was double entered using Epidata version 3.1
(Epidata Association, Odense, Denmark). The data was
checked for range and consistency. Data was transferred
to STATA version 11.0 (StataCorp LP, Texas, USA for
analysis and all P values were two tailed and P values
of <0.05 were considered to indicate statistical signifi-
cance. Categorical data was displayed as frequencies and
percentages.
The primary exposure dependent variable was RBC folate
level which was categorized into low folate (470.9 ng/ml or
less) and normal folate (471to 1289 ng/ml). The outcome
variable was breast cancer which was treated as a binary
variable: breast cancer cases and controls. All continuous
variables were arranged into categories to allow usage of
the Chi squared test.
Age was grouped into five categories: 18 to 39, 40 to
49, 50 to 59, 60 to 69, and 70 and above. Social and cul-
tural behavioral factors which were assumed to influence
participant’s dietary patterns were mainly determined by
looking at residence, which were categorized as rural ver-
sus urban. Body Mass Index was categorized as under-
weight (less than 18.5 kg/m2), normal (18.5 to 24.9 kg/m2),
overweight (25 to 29.9 kg/m2), and obese (30 kg/m plus2).
Parity was categorized as nulliparous (zero), low parity
(one to four), and mutiparity (five and above). Menopausal
status was binary; pre-menopausal and post-menopausal.
Menopause was defined as age at which the participant
ceased menstruation plus one year.
Hemoglobin level was categorized according to the
World Health Organization (WHO) guidelines for non-
pregnant women over the age of 15 years [6]; severe




Cases Controls P values*
n = 72 % n = 73 %
Age
20 – 39 15 21 15 21
40 – 49 13 18 15 21
50 - 59 23 23 23 23
60 - 69 11 15 11 15
70+ 10 14 9 12 0.996
Residence† 70 73
Rural 41 59 38 52
Urban 29 41 35 49 0.433
Body Mass Index
Underweight 1 1 4 6
Normal 38 53 29 40
Overweight 18 25 25 34
Obese 15 21 15 21 0.247
Contraceptive use
Yes 26 37 26 36
None 45 63 47 64 0.900
Menopause
Pre-menopause 28 39 31 43
Post-menopause 44 61 42 57.5 0.661
Parity
Null 6 8 1 1
Low parity 23 32 19 26
Multi parity 43 60 53 73 0.083
Alcohol use
Yes 43 60 30 41
No 29 40 43 59 0.25
Taking tobacco
Yes 5 7 9 13
No 67 93 63 88 0.261
*Chi square = P values.
Percentages may be = 100 due to rounding.
†Missing =2.
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anemia (11 to 11.9 g/dl) and normal (12 g/dl and above).
The other variables were categorized according to
whether the participant was identified with the variable or
not. Chi-square and logistic regression were used to exam-
ine the association between RBC folate levels and breast
cancer. Bivalent association between other factors and
having breast cancer was examined and presented as odds
ratio, and multivariate logistic regression was used to look
for potential confounders (age, parity, residence, B12,
BMI, alcohol, tobacco use and contraceptive use).
Quality control
Pre- testing of the questionnaire was done before the
study was carried out.
All patients were fully screened for inclusion and ex-
clusion according to the criteria that was set.
One laboratory was used and all tests were done by
two laboratory technologists experienced in using the
COBAS e601, for RBC folate and vitamin B12 tests.
Calibration of the COBAS e601 was done before sam-
ples (which had been stored as outlined above) were
processed.
Samples were kept in a freezer (Defy Kirsch, Germany)
at −20°C in the clinical chemistry laboratory for future re-
evaluation if need arose.
Ethical consideration
Institutional ethical approval was obtained from the Ethics
and Research Committees of Makerere University College
of Health Sciences. Written informed consent was ob-
tained from each study participant.
Results and discussion
Seventy two cases of breast cancer and 73 controls were
enrolled in the study from January 2012 to May 2012.
Two cases were not included in the analysis due to miss-
ing laboratory results. Study participants were compared
for study variables and results are shown in Table 1.
Age
The mean age for cases was 51 years (range 23 to 87) and
the mean age for controls was 52 years (range 23 to 80).
Tobacco usage
Only 14(10%) of women reported tobacco use, 6(4%) re-
ported smoking, 2(2%) reported use of a pipe and 6(4%)
reported chewing tobacco. The average frequency of use
of tobacco per day was 2.3 times ranging from one to
four times a week.
Age at menarche
The average age of menarche was 14 years (range 9 to 20).
The mean ages at menarche among cases and controlswere 14 (range 10 to 20) and 14 years (range 10 to 19),
respectively.
The overall average age at menopause was 48 years
(38 to 66). Among cases and controls, the average was
48 (40 to 66) and 49(38 to 55) years respectively.
Contraceptive use
The number of participants that reported using contra-
ceptives was 52 (36%) with an average duration of contra-
ceptive use of 4 years (range 1 to 15). Of these, 26 (37%)
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to 26 (36%) of controls.
Red blood cell folate levels
The mean RBC folate level was 430 ng/ml; range
(105 ng/ml to 857 ng/ml) as shown in Figure 1. Low
folate RBC was found in 90 participants (63%) (below
471 ng/ml – as was defined by this study) and 53 par-
ticipants (37%) had normal RBC folate. The mean RBC
folate for both cases and controls was below the cutoff
of what was defined as normal. Cases had a mean RBC
folate level of 445 (126 to 857 ng/ml) compared to
415 ng/ml, (105 to 734 ng/ml) among the controls.
Vitamin B12 levels
The average vitamin B12 level among women was
445 pg/ml (50 to 2000) with cases showing an average
of 492 ng/dl (50 to 2000) and controls an average of
401 ng/ml (58 to 1114). Figure 2 shows the distribution
of vitamin B12 levels among participants.
Hemoglobin levels
The mean hemoglobin level was 13 g/dl (6.6 g/dl to
16.7 g/dl), with a mean of 12.7 g/dl (6.6 to 16.3) and
13.7 g/dl (9.2 to 16.7 g/dl) among cases and control re-
spectively. See Figure 3 showing the distribution of
hemoglobin among participants.
Parity
Among cases, 6 participants were nulliparous (8%), 23
participants were of low parity (32%) and 43 were mul-
tiparous (60%). Among controls, 1 participant was nul-
liparous (1%), 19 participants had low parity (26%) and










0 200 400 600 800 1000
RBC folate level (ng/ml)
Cases of Breast Cancer
Figure 1 Histogram of RBC folate levels among study participants. RBBody mass index
Among the cases, one participant was underweight (1%),
38 participants had normal weight (53%), 18 participants
were overweight (25%) and 15 participants were obese
(21%). Among controls, 4 participants were underweight
6%, 29 participants had normal weight (40%), 25 partici-
pants were overweight (34%) and 15 participants were
obese (21%).
Alcohol consumption
Among the cases, 43 (60%) reported alcohol use com-
pared to 29 (40%) who reported no alcohol usage. Among
the controls, 30 (41%) reported alcohol usage compared
to 43 (59%) who reported no alcohol usage.
Residence
Among the cases, 41 (59%) were from rural areas and
29 (41%) were from urban areas. Among the controls,
38 (52%) were from rural areas compared to 35 (49%)
who were from urban areas.
Study variables and their association with RBC folate levels
Contraceptive use and area of residence were the only
characteristics associated with RBC folate levels (Table 2).
Thirty five women (45%) from rural residences had nor-
mal folate levels compared to 18 (28%) women from
urban residences. Thirteen (25%) women using contra-
ceptives had normal folate levels compared to 40 (44%)
women not using contraceptives.
Association between RBC Folate with breast cancer
There was no association seen between RBC folate levels
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Figure 2 Histogram of vitamin B12 folate levels among study participants.
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odds of having breast cancer among women with normal
folate levels compared to those with low folate levels
were 1.4 (95% CI 0.7 to 2.9), P value 0.291. Multivariate
logistic regression showed that none of the potential
confounding factors examined affected the association
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Figure 3 Histogram of haemoglobin levels among study participants.Association with other study variables
Examination of the crude association between other stu-
dy variables using Pearson’s chi-squared test (χ2), showed
that alcohol use was associated with having breast cancer
(Table 3). Women who reported alcohol use had 2:1 odds
of breast cancer compared to those with no alcohol use
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Table 2 The association between study participants and
red blood cell folate levels
Characteristics
n = 145
Cases Controls P values*
n = 72 % n = 73 %
Age
20 – 39 22 24 8 15
40 – 49 18 20 10 18
50 - 59 25 28 19 36
60 - 69 16 18 6 11
70+ 9 10 10 19 0.288
Residence†
Rural 43 48 35 66.0
Urban 46 52 18 34.0 0.040
Body Mass Index
Underweight 3 03 2 4
Normal 39 43 26 49
Overweight 28 31 15 28
Obese 20 22 10 19 0.913
Contraceptive use
Yes 39 44 13 25
None 50 56 40 76 0.021
Menopause
Pre-menopause 38 42 21 40
Post-menopause 52 58 32 60 0.661
Parity
Null 5 6 2 4
Low parity 27 30 15 28
Multi parity 58 64 36 68 0.856
Alcohol use
Yes 43 48 23 56.6
No 47 52 30 43.4 0.308
Taking tobacco
Yes 7 8 7 13.2
No 82 92 46 86.8 0.320
Hemoglobin
Severe anaemia 0 0 2 4
Moderate anaemia 7 8 7 13
Mild anaemia 8 9 5 9
Normal 75 83 39 74 0.186
Vitamin B12
Low 24 27 15 28
Normal 66 73 38 72 0.832
*Chi square = p values.
Percentages may be = 100 due to rounding.
†Missing =2.
Table 3 Bivariate analysis of risk factors associated with
having cancer of the breast at Mulago hospital
Characteristics n = 145 Crude odds ratio (95%) P values
RBC folate level
Low Referent
Normal 1.4 (0.7– 2.9) 0.291
Vitamin B12
Low Referent
Lower normal 0.9 (0.4 – 2.0) 0.835
Upper normal 1.3 (0.5 – 3.4) 0.599
Age
20 – 39 Referent
40 – 49 0.9 (0.3 – 2.4) 0.786
50 - 59 1.0 (0.4 - 0.5) 1.000
60 - 69 1.0 (0.3 – 3.0) 1.000
70+ 1.1 (0.4 – 3.5) 0.858
Residence
Rural Referent
Urban 0.8 (0.40 – 1.5) 0.434
Body Mass Index
Underweight Referent
Normal weight 5.2 (0.6 – 49.4) 0.148
Overweight 2.9 (0.3 – 28.0) 0.362
Obese 4.0 (0.4 – 40.1) 0.239
Contraceptive use
None Referent
Yes 1.0 (0.5– 2.1) 0.900
Parity
Null Referent
Low parity 0.2 (0.1 – 2.0) 0.166
Multi parity 0.3 (0.1– 2.5) 0.253
Alcohol use
No Referent
Yes 2.1 (1.1-4.1) 0.026
Taking tobacco
No Referent
Yes 0.5 (0.2 – 0.6) 0.267
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shown in Table 3. Results of the association of RBC folate
and vitamin B12 were also tabulated in this table.
Discussion
The aim of the study was to determine the association
between RBC folate levels and breast cancer. There was
no significant association found, the odds of having breast
cancer among women with normal folate levels compared
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P = 0.291.
Folate plays a very important biochemical role in DNA
synthesis, repair and methylation [3]. Folate is essential
for regenerating methionine, the methyl donor for DNA
methylation [7]. Folate is also essential for producing the
purines and pyrimidine thymidylate required for DNA
synthesis and repair [3]. Regeneration of methionine from
homocysteine requires 5 methyl- THF as a substrate and
Vitamin B12 as a cofactor [7]. Base modifications are in-
volved in DNA packaging, with regions that have low or
no gene expression usually containing high levels of
methylation of cytosine bases [8].
Cytosine methylation produces 5-methylcytosine, which
is important for chromosome inactivation. It has therefore
been hypothesized that high intake of folate may reduce
the risk of human cancers, including breast cancer [3].
Though not statistically significant, our findings sug-
gest that females with low folate are less likely to have
breast cancer when compared with females who have nor-
mal folate levels. This may mean that the observed higher
RBC folate among cases may be associated with breast
cancer. However, the observation of lower RBC folate
among controls may also mean that low folate is protect-
ive against early breast carcinogenesis. These observations
may lend themselves to other studies that have suggested
that high folate is associated with breast cancer events,
and that low folate is protective against breast cancer. This
dual modulatory effect of folate on cancer has been ob-
served by other epidemiologic, clinical, and animal studies
[9]. The observation in this study is also in agreement with
similar studies (both were case control studies and serum
folate was used as a measure of association) by Wu et al.
in 1999 and Rossi et al. in 2006 [10,11]. The observation
is also consistent with studies that did not find any associ-
ation between dietary folate and breast cancer [9,12,13].
However, other studies suggest that high folate (serum fol-
ate, RBC folate and dietary folate) is associated with re-
duced risk of breast cancer [3,7,9].
RBC folate levels among participants
We observed that females in our study had lower RBC
folate than those from other countries, including China,
Mexico and Australia where most of the studies on the
association between RBC folate and breast cancer have
been conducted [9,12-15], though a recent Ugandan study
suggested no difference [16]. This low folate is probably
due to a low folate intake among the Ugandan population
when compared to the western world.
Both the mean and range of RBC folate levels was
slightly higher among cases, although this observation
was not statistically significant. It is possible that the
reason for this disparity lies in the fact that the breast
cancer patients seen are prevalent rather than incidentcases, and dietary changes due to nutritional improve-
ment following illness may occur during the course of
the disease which may affect RBC folate levels. On the
other hand, since the difference among cases and con-
trols is not statistically significant, the observed differ-
ence may not merit further scrutiny.
Potential confounding factors
Confounding factors that were studied were not found
to have an effect on the association between RBC folate
and breast cancer. These included age, residence, alcohol
use, BMI, tobacco use, hormonal contraceptive use, me-
nopausal status, vitamin B12 levels, hemoglobin level,
parity, and age at menarche and menopause.
Association between BMI and area of residence
This study showed that 43% of study participants from
rural areas were either overweight or obese compared to
62% overweight or obese participants from urban areas.
This observation shows that living in urban settings is
associated with either overweight or obese BMIs when
compared to leaving in rural areas. Participants of a nor-
mal weight were found to differ considerably based on
area, with 51% of participants coming from rural areas
compared to only 34% coming from urban areas. Social
and dietary habits may be the contributing factor, as par-
ticipants from an urban area are more exposed to proc-
essed foodstuffs and drinks which may be rich in fats and
calories, compared to participants from rural areas whose
diet may mainly be based on cereals and fresh foods.
Association between BMI and age
The average age of underweight participants was 64,that
of normal weight participants was 52, that of overweight
participants was 49, and that of obese participants was
52. Although underweight is observed to be associated
with older age, other age categories were not associated
with BMI. The observed low BMI among elderly partici-
pants may be due to the reduced general health status
that is associated with this age group.
In this study, we used RBC folate levels instead of
serum folate levels [11,17] given that RBC folate levels
are more representative of long-term folate status as com-
pared to serum levels that assess short-term status.
Limitations of the study
This study used the RBC folate cutoffs from the Australian
population (471 ng/ml). Though this was found to be
higher than the average RBC folate of the study controls,
an earlier study observed that the status of folate levels
among healthy young individuals was not different from
that in Australia [16].
It was not possible to study only incident cases as pa-
tients are likely to seek care from other sources before
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the pre-morbid folate status may have been altered by
interventions such as herbal medication (which may be
rich in folate).
Dietary history was not obtained because of lack of a
contextually appropriate tool. This would have provided
a more accurate pre-morbid folate exposure.
Vitamin B6 (pyridoxine) was not studied yet it is an
obligate cofactor, together with vitamin B12, for the con-
version to the form of folate used for DNA synthesis
and methylation.
Both the cases and controls may not have been true
representatives of the general population given the fact
that this was a hospital-based study, although this hos-
pital is the only public institution with free comprehensive
breast cancer services in the country and the majority of
patients depend on free health care.
There could have been recall bias, for other variables
such as age, contraceptive use though the main predictor
variable was a biomarker which is not influenced by
what a participant may recall.
Conclusions
There was no association found between RBC folate levels
and breast cancer.
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